● Single award · contract
Advanced Research and Development Activities for Novel Immunogenicity Assays and Sample Collection…
A single federal award, with both ends of the trail linked.
$126.5M
total award value
2023
action date
72 mo
period
75A50123C00045
PIID
Description
Advanced Research and Development Activities for Novel Immunogenicity Assays and Sample Collection Technologies as Part of Barda?s Continuing Support for COVID-19 Vaccine Development, Assessing Impact of Variants on Vaccine Immunogenicity, and Analyz
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceNorth Carolina →
CategoryNAICS 541715PSC AN12
Competed?Not recorded✓ from source
Total (exact)$126,485,055
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.